The medication may have been exposed to temperatures well above 86 degrees Fahrenheit during shipping, especially in summer months
Tirzepatide is a dual GIP/GLP-1 receptor agonist, which may lead to stronger appetite reduction and greater average weight loss for some patients
GLP-1 receptor agonist weight-regain meta-regression
You should be especially cautious if you have a history of pancreatitis, gallbladder disease, liver disease, diabetes, frequent low blood sugar, heavy alcohol use, or medications that should not be mixed with alcohol
Nevertheless, technological advances have expanded the targets of prebiotics beyond Lactobacillus and Bifidobacterium , to other newly identified health-promoting gut microbes, such as Roseburia, Eubacterium , and Faecalibacterium spp
A 2021 study shows that taking a semaglutide, like Wegovy, may increase your risk of developing deep vein thrombosis by up to 266%